Ignite Creation Date:
2025-12-25 @ 12:06 AM
Ignite Modification Date:
2026-02-07 @ 11:40 PM
Study NCT ID:
NCT03257358
Status:
COMPLETED
Last Update Posted:
2021-10-07
First Post:
2017-08-18
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Immune Phenotype Biomarkers in Patients With Relapsing Multiple Sclerosis (RMS) After Treatment With 0.5mg Fingolimod
Sponsor:
Novartis Pharmaceuticals
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Relapsing Multiple Sclerosis | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Relapsing Multiple Sclerosis | View |
| None | RMS | View |
| None | Relapsing Multiple Sclerosis (RMS) | View |
| None | Multiple Sclerosis | View |
| None | MS | View |
| None | Multiple Sclerosis (MS) | View |
| None | Fingolimod | View |
| None | FLUENT | View |
| None | Immune Phenotype | View |
| None | adult | View |
| None | FTY720 | View |